Jeffrey Gudin
2020
In 2020, Jeffrey Gudin earned a total compensation of $173K as Executive VP, Chief Medical Officer at Virpax Pharmaceuticals.
Compensation breakdown
| Option Awards | $173,000 |
|---|---|
| Total | $173,000 |
Gudin received $173K in option awards, accounting for 100% of the total pay in 2020.
Rankings
In 2020, Jeffrey Gudin's compensation ranked 12,685th out of 13,090 executives tracked by ExecPay. In other words, Gudin earned more than 3.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,685 out of 13,090 | 3rd |
Division Manufacturing | 5,441 out of 5,621 | 3rd |
Major group Chemicals And Allied Products | 2,196 out of 2,254 | 3rd |
Industry group Drugs | 1,908 out of 1,954 | 2nd |
Industry Pharmaceutical Preparations | 1,422 out of 1,459 | 3rd |
Source: SEC filing on June 15, 2022.
Gudin's colleagues
We found two more compensation records of executives who worked with Jeffrey Gudin at Virpax Pharmaceuticals in 2020.